Testing the regulatory framework in South Africa – a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis

Testing the regulatory framework in South Africa – a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis

Abstract Background Bacterial vaginosis (BV) increases HIV risk and adverse reproductive outcomes. Standard-of-care (SOC) for BV are antibiotics; however, cure rates are low. Probiotics for vaginal health may be useful in improving cure and recurrence although the regulatory framework governing prob...

Full description

Bibliographic Details
Main Authors: Anna-Ursula Happel, Ravesh Singh, Nireshni Mitchev, Koleka Mlisana, Heather B. Jaspan, Shaun L. Barnabas, Jo-Ann S. Passmore
Format: Article
Language:English
Published: BMC 2020-07-01
Series:BMC Infectious Diseases
Subjects:
BV
Probiotics
Regulation
South Africa
SAHPRA
Vaginal health
Online Access:http://link.springer.com/article/10.1186/s12879-020-05210-4

Internet

http://link.springer.com/article/10.1186/s12879-020-05210-4

Similar Items